Condrosulf 400
Condrosulf 400 is a medicine authorised by Swissmedic under authorisation number 48557. The authorisation holder is IBSA Institut Biochimique SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 December 1986 and the authorisation is valid without a time limit. ATC code M01AX25 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 48557 |
|---|---|
| Name | Condrosulf 400 |
| Full name | Condrosulf 400, granulato in bustine |
| Authorisation holder | IBSA Institut Biochimique SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AX25 |
| First authorisation | 29 December 1986 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Condrosulf 400, granulato in bustine | B | 29 December 1986 |
| 2 | Condrosulf 800, granulato in bustine | B | 20 September 1989 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 60 | Sachet(s) | M01AX25 | 07.10.6. | B |
| 66 | 180 | Sachet(s) | M01AX25 | 07.10.6. | B |
| 31 | 30 | Sachet(s) | M01AX25 | 07.10.6. | B |
| 58 | 90 | Sachet(s) | M01AX25 | 07.10.6. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Condrosulf 400 authorised in Switzerland?
Yes. Condrosulf 400 is authorised by Swissmedic under authorisation number 48557, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Condrosulf 400 have?
Condrosulf 400 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Condrosulf 400?
The authorisation holder is IBSA Institut Biochimique SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.